Foresee Pharmaceuticals Co., Ltd. (6576.TWO)
TWD 75.9
(0.0%)
TWD 75.9
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -887.55 Million | -233.22 Million | -213.33 Million | -674.79 Million | -447.81 Million |
| Net Income | -988.63 Million | -438.13 Million | -527.99 Million | -482.81 Million | -487.21 Million |
| Depreciation & Amortization | 73.62 Million | 51.15 Million | 51.47 Million | 49.48 Million | 39.19 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 50.77 Million | 40.17 Million | 23.92 Million | 22.88 Million | 19.43 Million |
| Change in working capital | 23.64 Million | 146.22 Million | 290.62 Million | -240.54 Million | 48.52 Million |
| Other non-cash items | -20.67 Million | -7.93 Million | -12.97 Million | 668 Thousand | -67.75 Million |
| Investing Cash Flow | -296.07 Million | 40.7 Million | 17.62 Million | -153.03 Million | -172.4 Million |
| Investments in PPE | -46.28 Million | -58.06 Million | -7.64 Million | -28.18 Million | -86.52 Million |
| Acquisitions | 229 Thousand | - | - | - | - |
| Investment purchases | -249 Million | - | - | -125 Million | - |
| Sales/Maturities of investments | - | 100 Million | 25 Million | - | - |
| Other Investing Activities | -1.02 Million | -1.22 Million | 267 Thousand | 152 Thousand | -85.87 Million |
| Financing Cash Flow | 1.5 Billion | 2.85 Million | -75.74 Million | 1.52 Billion | 855.36 Million |
| Debt repayment | -200 Million | - | -104.07 Million | -114.6 Million | -11.15 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 1.31 Billion | 14.2 Million | 38.43 Million | 1.42 Billion | 866.52 Million |
| Other Financing Activities | -15.51 Million | - | - | - | 866.52 Million |
| Accounts receivables | -49.64 Million | - | - | - | 101 Thousand |
| Accounts payables | -10.72 Million | - | - | - | - |
| Inventory | 49.6 Million | -151.52 Million | 40.09 Million | 32.82 Million | - |
| Other working capital | 23.67 Million | - | - | - | 48.42 Million |
| Cash at beginning of period | 689.5 Million | 871.43 Million | 1.14 Billion | 448.01 Million | 214.33 Million |
| Cash at end of period | 1 Billion | 689.5 Million | 871.43 Million | 1.14 Billion | 448.01 Million |
| Capital Expenditure | -46.28 Million | -58.06 Million | -7.64 Million | -28.18 Million | -86.52 Million |
| Effect of forex changes on cash | -90 Thousand | 7.73 Million | -2.22 Million | -3.71 Million | -1.46 Million |
| Net cash flow / Change in cash | 320.17 Million | -181.93 Million | -273.68 Million | 697.1 Million | 233.68 Million |
| Free Cash Flow | -933.83 Million | -291.29 Million | -220.97 Million | -702.97 Million | -534.34 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -152.91 Million | -107.85 Million | -330.73 Million | -988.63 Million | -215.83 Million | -269.16 Million |
| Depreciation & Amortization | 20.27 Million | 20.24 Million | 19.96 Million | 73.62 Million | 18.58 Million | 17.66 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 8.09 Million | 11.63 Million | 11.52 Million | 50.77 Million | 12.41 Million | 17.65 Million |
| Change in working capital | 40.72 Million | -72.96 Million | 12.27 Million | 23.64 Million | -4.12 Million | 52.52 Million |
| Other non-cash items | -7.25 Million | -7.24 Million | -8.71 Million | -20.67 Million | -8.31 Million | -1.47 Million |
| Investing Cash Flow | -20.82 Million | 233.02 Million | -67.97 Million | -296.07 Million | -152.99 Million | -55.11 Million |
| Investments in PPE | -21.18 Million | -9.72 Million | -16.88 Million | -46.28 Million | -4.6 Million | -4.86 Million |
| Acquisitions | 211 Thousand | - | - | - | - | - |
| Investment purchases | - | -50 Million | -50 Million | -249 Million | -148.3 Million | -50.69 Million |
| Sales/Maturities of investments | - | 292.5 Million | - | - | - | - |
| Other Investing Activities | 149 Thousand | 250 Thousand | -1.09 Million | -1.02 Million | -83 Thousand | 448 Thousand |
| Financing Cash Flow | -2.2 Million | 3.72 Million | 98.79 Million | 1.5 Billion | -3.56 Million | 1.4 Billion |
| Debt repayment | -4.05 Million | - | -100 Million | -200 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.85 Million | 7.9 Million | 2.84 Million | 1.31 Billion | 369 Thousand | 1.3 Billion |
| Other Financing Activities | 1.85 Million | - | - | - | - | - |
| Accounts receivables | 32.01 Million | - | - | - | - | - |
| Accounts payables | 23.97 Million | - | - | - | - | - |
| Inventory | -26.97 Million | 23.4 Million | 13.25 Million | 49.6 Million | 10.95 Million | -17.02 Million |
| Other working capital | 11.71 Million | - | - | - | - | - |
| Cash at beginning of period | 1.09 Billion | 1 Billion | 1.28 Billion | 689.5 Million | 1.64 Billion | 487.41 Million |
| Cash at end of period | 972.75 Million | 1.09 Billion | 1 Billion | 1 Billion | 1.28 Billion | 1.64 Billion |
| Capital Expenditure | -21.18 Million | -9.72 Million | -16.88 Million | -46.28 Million | -4.6 Million | -4.86 Million |
| Effect of forex changes on cash | 4.59 Million | 5.66 Million | -5.38 Million | -90 Thousand | 3.5 Million | 2.58 Million |
| Net cash flow / Change in cash | -117.34 Million | 80.41 Million | -278.67 Million | 320.17 Million | -359.89 Million | 1.16 Billion |
| Free Cash Flow | -120.09 Million | -171.72 Million | -320.99 Million | -933.83 Million | -211.44 Million | -196.86 Million |
0R02
QRS
XPL
PIK
NLSP
ABDN